Rchr
J-GLOBAL ID:200901011465744340   Update date: Nov. 11, 2024

Fukuda Shinji

フクダ シンジ | Fukuda Shinji
Affiliation and department:
Job title: 講師
Research field  (3): Oral medicine (pathology) ,  Molecular biology ,  Pathobiochemistry
Research keywords  (1): シグナル伝達
Research theme for competitive and other funds  (14):
  • 2021 - 2024 膜型増殖因子と受容体の発光蛍光デュアルイメージングによる歯肉がんの浸潤機構の解析
  • 2019 - 2021 Development and application of disease-specific protein targeting system
  • 2018 - 2021 test
  • 2018 - 2021 Functional analysis of the cell polarity regulatory complex Exocyst-Par3 in mammary epithelial cells
  • 2015 - 2019 Reversible interconversin of mammary epithelial cells by EGF ligands
Show all
Papers (32):
  • Hotsuna Ninomiya, Shinji Fukuda, Hisayo Nishida-Fukuda, Yuto Shibata, Takuma Sato, Yuko Nakamichi, Midori Nakamura, Nobuyuki Udagawa, Ken Miyazawa, Takahiro Suzuki. Osteoprotegerin secretion and its inhibition by RANKL in osteoblastic cells visualized using bioluminescence imaging. Bone. 2024. 117319-117319
  • Shinya Sato, Yukiko Mizutani, Minori Abe, Shinji Fukuda, Shigeki Higashiyama, Shintaro Inoue. Naked mole-rat TMEM2 lacks physiological hyaluronan-degrading activity. Archives of biochemistry and biophysics. 2024. 110098-110098
  • Shinya Sato, Megumi Miyazaki, Shinji Fukuda, Yukiko Mizutani, Yoichi Mizukami, Shigeki Higashiyama, Shintaro Inoue. Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199/CEMIP) and HAS2 expression. The Journal of biological chemistry. 2023. 299. 6. 104826-104826
  • Jun Muto, Shinji Fukuda, Kenji Watanabe, Xiuju Dai, Teruko Tsuda, Takeshi Kiyoi, Kenji Kameda, Ryosuke Kawakami, Hideki Mori, Ken Shiraishi, et al. Highly concentrated trehalose induces prohealing senescence-like state in fibroblasts via CDKN1A/p21. Communications Biology. 2023. 6. 1
  • Felix Seefried, Lucia Haller, Shinji Fukuda, Aranya Thongmao, Nadja Schneider, Jochen Utikal, Shigeki Higashiyama, Anja Katrin Bosserhoff, Silke Kuphal. Nuclear AREG affects a low-proliferative phenotype and contributes to drug resistance of melanoma. International journal of cancer. 2022. 151. 12. 2244-2264
more...
MISC (14):
  • 佐藤伸哉, 佐藤伸哉, 宮崎恵, 水谷有紀子, 福田信治, 東山繁樹, 井上紳太郎. Human TMEM2 is not a hyaluronidase. 日本結合組織学会学術大会抄録集. 2022. 54th (Web). 76-76
  • 武藤 潤, 福田 信治, 白石 研, 森 秀樹, 村上 正基, 東山 繁樹, 佐山 浩二. 糖鎖を用いた自家細胞由来3次元皮膚シート作製法開発. 日本結合組織学会学術大会プログラム・抄録集. 2020. 52回. 74-74
  • 佐藤伸哉, 増田愛美, 宮崎恵, 水谷有紀子, 福田信治, 東山繁樹, 井上紳太郎. Human TMEM2 is not a hyaluronidase, but rather a regulator that increases high-molecular-weight hyaluronan. 日本結合組織学会学術大会抄録集. 2020. 52nd. 64-64
  • 近藤 綾乃, 松木 依理奈, 楠本 智章, 藤原 章, 坂上 倫久, 前川 大志, 藤崎 亜耶子, 福田 信治, 東山 繁樹, 中山 寛尚. Cullin-3ユビキチン複合体による膜型メタロプロテアーゼ制御機構解析. 臨床検査学教育. 2019. 11. 1. 113-114
  • Yoshinori Ohno, Mitsuhito Koizumi, Hironao Nakayama, Takao Watanabe, Masashi Hirooka, Yohei Koizumi, Yoshio Tokumoto, Taira Kuroda, Shinji Fukuda, Shigeki Higashiyama, et al. Down-regulated acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) has a role in suppression of apoptosis, and is associated with poor prognosis in patients with hepatocellular carcinoma. HEPATOLOGY. 2016. 64. 358A-359A
more...
Books (1):
  • 分子生物学イラストレイテッド
    2009
Education (3):
  • 1999 - 2002 Kyushu University
  • 1997 - 1999 Kyushu University
  • 1993 - 1997 Kyushu University School of Sciences Department of Biology
Professional career (1):
  • 博士(理学) (九州大学)
Work history (8):
  • 2020 - 現在 Aichi Gakuin University Department of Biochemistry, School of Dentistry Assistant Professor
  • 2021 - 2023 Iwate Medical University
  • 2016 - 2020 Ehime University Proteo-Science Center, Division of Cell growth & tumor regulation
  • 2016 - 2018 Vanderbilt University, Visiting Research Fellow
  • 2014 - 2016 Ehime University Proteo-Science Center, Division of Cell growth & tumor regulation
Show all
Association Membership(s) (4):
日本分子生物学会 ,  日本病態プロテアーゼ学会 ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE BIOCHEMICAL SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page